Moreover, modifications in the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), the rate-limiting enzyme of the kynurenine pathway, were reported in PCOS, which may lead to important imbalances between metabolites of the two pathways engaged in tryptophan metabolism [20]. The gene discussed is IDO2; the disease is polycystic ovary syndrome.